Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension
Abstract Background Giardia duodenalis is a prevalent gastrointestinal parasite in dogs, causing diarrhea, vomiting, and weight loss. Metronidazole is a common treatment for this infection. This study aimed to evaluate the efficacy, safety, and acceptance of a flavored liquid metronidazole oral susp...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Parasites & Vectors |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13071-025-06797-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849309779929858048 |
|---|---|
| author | Sloane Jones Philippe Briantais Cristiano Von Simson Eleonore De Meyrignac Laure Poincelot Delphine Rigaut |
| author_facet | Sloane Jones Philippe Briantais Cristiano Von Simson Eleonore De Meyrignac Laure Poincelot Delphine Rigaut |
| author_sort | Sloane Jones |
| collection | DOAJ |
| description | Abstract Background Giardia duodenalis is a prevalent gastrointestinal parasite in dogs, causing diarrhea, vomiting, and weight loss. Metronidazole is a common treatment for this infection. This study aimed to evaluate the efficacy, safety, and acceptance of a flavored liquid metronidazole oral suspension in treating G. duodenalis in naturally infected dogs. Methods A double-masked, vehicle-controlled, randomized, multi-center clinical field trial was conducted. Client-owned dogs with confirmed G. duodenalis infections were enrolled and randomized into AYRADIA-treated and control groups. The AYRADIA group received the metronidazole suspension at 0.2 ml/kg twice daily for 5 days, while the control group received a flavored vehicle suspension without metronidazole. Fecal samples were collected before and after treatment to assess G. duodenalis cyst counts. Clinical examinations and owner assessments were also performed to evaluate safety and treatment acceptance. Results The study enrolled 180 dogs, with 129 included in the efficacy analysis. AYRADIA treatment resulted in a 99.92% reduction in G. duodenalis cyst counts, significantly higher than the reduction in the control group. Adverse events were similar between both groups (10%), mainly consisting of diarrhea and vomiting. The treatment was readily accepted by 99% of dogs. Conclusions AYRADIA, administered at 0.2 ml/kg twice daily for 5 days, is highly effective in treating G. duodenalis infections in dogs. The treatment demonstrated a positive safety profile and excellent acceptance. This flavored oral suspension offers a valuable and convenient option for veterinarians managing giardiasis in dogs. Graphical Abstract |
| format | Article |
| id | doaj-art-0ed014c6646f4dbd8c25d45cfcb199b2 |
| institution | Kabale University |
| issn | 1756-3305 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | BMC |
| record_format | Article |
| series | Parasites & Vectors |
| spelling | doaj-art-0ed014c6646f4dbd8c25d45cfcb199b22025-08-20T03:53:58ZengBMCParasites & Vectors1756-33052025-05-011811710.1186/s13071-025-06797-wTreatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspensionSloane Jones0Philippe Briantais1Cristiano Von Simson2Eleonore De Meyrignac3Laure Poincelot4Delphine Rigaut5Virbac CorporationVirbacVirbac CorporationVirbacVirbacVirbacAbstract Background Giardia duodenalis is a prevalent gastrointestinal parasite in dogs, causing diarrhea, vomiting, and weight loss. Metronidazole is a common treatment for this infection. This study aimed to evaluate the efficacy, safety, and acceptance of a flavored liquid metronidazole oral suspension in treating G. duodenalis in naturally infected dogs. Methods A double-masked, vehicle-controlled, randomized, multi-center clinical field trial was conducted. Client-owned dogs with confirmed G. duodenalis infections were enrolled and randomized into AYRADIA-treated and control groups. The AYRADIA group received the metronidazole suspension at 0.2 ml/kg twice daily for 5 days, while the control group received a flavored vehicle suspension without metronidazole. Fecal samples were collected before and after treatment to assess G. duodenalis cyst counts. Clinical examinations and owner assessments were also performed to evaluate safety and treatment acceptance. Results The study enrolled 180 dogs, with 129 included in the efficacy analysis. AYRADIA treatment resulted in a 99.92% reduction in G. duodenalis cyst counts, significantly higher than the reduction in the control group. Adverse events were similar between both groups (10%), mainly consisting of diarrhea and vomiting. The treatment was readily accepted by 99% of dogs. Conclusions AYRADIA, administered at 0.2 ml/kg twice daily for 5 days, is highly effective in treating G. duodenalis infections in dogs. The treatment demonstrated a positive safety profile and excellent acceptance. This flavored oral suspension offers a valuable and convenient option for veterinarians managing giardiasis in dogs. Graphical Abstracthttps://doi.org/10.1186/s13071-025-06797-wGiardiaMetronidazoleDogCanineTreatment |
| spellingShingle | Sloane Jones Philippe Briantais Cristiano Von Simson Eleonore De Meyrignac Laure Poincelot Delphine Rigaut Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension Parasites & Vectors Giardia Metronidazole Dog Canine Treatment |
| title | Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension |
| title_full | Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension |
| title_fullStr | Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension |
| title_full_unstemmed | Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension |
| title_short | Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension |
| title_sort | treatment of giardiasis in dogs field clinical study to confirm the efficacy safety and acceptance of a metronidazole based flavored oral suspension |
| topic | Giardia Metronidazole Dog Canine Treatment |
| url | https://doi.org/10.1186/s13071-025-06797-w |
| work_keys_str_mv | AT sloanejones treatmentofgiardiasisindogsfieldclinicalstudytoconfirmtheefficacysafetyandacceptanceofametronidazolebasedflavoredoralsuspension AT philippebriantais treatmentofgiardiasisindogsfieldclinicalstudytoconfirmtheefficacysafetyandacceptanceofametronidazolebasedflavoredoralsuspension AT cristianovonsimson treatmentofgiardiasisindogsfieldclinicalstudytoconfirmtheefficacysafetyandacceptanceofametronidazolebasedflavoredoralsuspension AT eleonoredemeyrignac treatmentofgiardiasisindogsfieldclinicalstudytoconfirmtheefficacysafetyandacceptanceofametronidazolebasedflavoredoralsuspension AT laurepoincelot treatmentofgiardiasisindogsfieldclinicalstudytoconfirmtheefficacysafetyandacceptanceofametronidazolebasedflavoredoralsuspension AT delphinerigaut treatmentofgiardiasisindogsfieldclinicalstudytoconfirmtheefficacysafetyandacceptanceofametronidazolebasedflavoredoralsuspension |